Literature DB >> 29643510

Intra-tumour diversification in colorectal cancer at the single-cell level.

Sophie F Roerink1, Nobuo Sasaki2,3, Henry Lee-Six1, Matthew D Young1, Ludmil B Alexandrov4,5,6, Sam Behjati1,7, Thomas J Mitchell1,8, Sebastian Grossmann1, Howard Lightfoot1, David A Egan9,10, Apollo Pronk11, Niels Smakman11, Joost van Gorp12, Elizabeth Anderson1, Stephen J Gamble1, Chris Alder1, Marc van de Wetering2, Peter J Campbell1, Michael R Stratton13, Hans Clevers14.   

Abstract

Every cancer originates from a single cell. During expansion of the neoplastic cell population, individual cells acquire genetic and phenotypic differences from each other. Here, to investigate the nature and extent of intra-tumour diversification, we characterized organoids derived from multiple single cells from three colorectal cancers as well as from adjacent normal intestinal crypts. Colorectal cancer cells showed extensive mutational diversification and carried several times more somatic mutations than normal colorectal cells. Most mutations were acquired during the final dominant clonal expansion of the cancer and resulted from mutational processes that are absent from normal colorectal cells. Intra-tumour diversification of DNA methylation and transcriptome states also occurred; these alterations were cell-autonomous, stable, and followed the phylogenetic tree of each cancer. There were marked differences in responses to anticancer drugs between even closely related cells of the same tumour. The results indicate that colorectal cancer cells experience substantial increases in somatic mutation rate compared to normal colorectal cells, and that genetic diversification of each cancer is accompanied by pervasive, stable and inherited differences in the biological states of individual cancer cells.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29643510     DOI: 10.1038/s41586-018-0024-3

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  156 in total

Review 1.  Cancer drug development: The missing links.

Authors:  Ajaikumar B Kunnumakkara; Devivasha Bordoloi; Bethsebie Lalduhsaki Sailo; Nand Kishor Roy; Krishan Kumar Thakur; Kishore Banik; Mehdi Shakibaei; Subash C Gupta; Bharat B Aggarwal
Journal:  Exp Biol Med (Maywood)       Date:  2019-04-08

Review 2.  Genomic evolution of cancer models: perils and opportunities.

Authors:  Uri Ben-David; Rameen Beroukhim; Todd R Golub
Journal:  Nat Rev Cancer       Date:  2019-02       Impact factor: 60.716

3.  Patient-Derived Cancer Organoid Cultures to Predict Sensitivity to Chemotherapy and Radiation.

Authors:  Cheri A Pasch; Peter F Favreau; Alexander E Yueh; Christopher P Babiarz; Amani A Gillette; Joe T Sharick; Mohammad Rezaul Karim; Kwangok P Nickel; Alyssa K DeZeeuw; Carley M Sprackling; Philip B Emmerich; Rebecca A DeStefanis; Rosabella T Pitera; Susan N Payne; Demetra P Korkos; Linda Clipson; Christine M Walsh; Devon Miller; Evie H Carchman; Mark E Burkard; Kayla K Lemmon; Kristina A Matkowskyj; Michael A Newton; Irene M Ong; Michael F Bassetti; Randall J Kimple; Melissa C Skala; Dustin A Deming
Journal:  Clin Cancer Res       Date:  2019-06-07       Impact factor: 12.531

4.  Single-cell DNA sequencing reveals complex mechanisms of resistance to quizartinib.

Authors:  Cheryl A C Peretz; Lisa H F McGary; Tanya Kumar; Hunter Jackson; Jose Jacob; Robert Durruthy-Durruthy; Mark J Levis; Alexander Perl; Benjamin J Huang; Catherine C Smith
Journal:  Blood Adv       Date:  2021-03-09

Review 5.  Tumor targeting via EPR: Strategies to enhance patient responses.

Authors:  Susanne K Golombek; Jan-Niklas May; Benjamin Theek; Lia Appold; Natascha Drude; Fabian Kiessling; Twan Lammers
Journal:  Adv Drug Deliv Rev       Date:  2018-07-19       Impact factor: 15.470

Review 6.  Organoid models for translational pancreatic cancer research.

Authors:  Hervé Tiriac; Dennis Plenker; Lindsey A Baker; David A Tuveson
Journal:  Curr Opin Genet Dev       Date:  2019-03-04       Impact factor: 5.578

7.  Association of aberrant ASNS imprinting with asparaginase sensitivity and chromosomal abnormality in childhood BCP-ALL.

Authors:  Atsushi Watanabe; Kunio Miyake; Jessica Nordlund; Ann-Christine Syvänen; Louise van der Weyden; Hiroaki Honda; Norimasa Yamasaki; Akiko Nagamachi; Toshiya Inaba; Tomokatsu Ikawa; Kevin Y Urayama; Nobutaka Kiyokawa; Akira Ohara; Shunsuke Kimura; Yasuo Kubota; Junko Takita; Hiroaki Goto; Kimiyoshi Sakaguchi; Masayoshi Minegishi; Shotaro Iwamoto; Tamao Shinohara; Keiko Kagami; Masako Abe; Koshi Akahane; Kumiko Goi; Kanji Sugita; Takeshi Inukai
Journal:  Blood       Date:  2020-11-12       Impact factor: 22.113

Review 8.  Clonal expansion in non-cancer tissues.

Authors:  Nobuyuki Kakiuchi; Seishi Ogawa
Journal:  Nat Rev Cancer       Date:  2021-02-24       Impact factor: 60.716

9.  Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity.

Authors:  Peter C Hart; Preety Bajwa; Hilary A Kenny
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 10.  Molecular subtyping of colorectal cancer: Recent progress, new challenges and emerging opportunities.

Authors:  Wei Wang; Raju Kandimalla; Hao Huang; Lina Zhu; Ying Li; Feng Gao; Ajay Goel; Xin Wang
Journal:  Semin Cancer Biol       Date:  2018-05-18       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.